News from the FDA/CDC
The templates aim to ease the submission process for manufacturers.
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.
Scrolling through GoFundMe reveals seemingly an endless number of people who need help or support. A common theme: the cost of health care.
Prior to approval, vigabatrin had been included on an FDA list of off-patent, off-exclusivity branded drugs without approved generics.
There was a linear decrease in prevalence of migraine leading up to T2DM diagnosis among those who were eventually diagnosed with it.
Around one-half of women and one-third of men will develop dementia, stroke, or parkinsonism during their lifetime,...
Infusion of allogeneic BK virus-specific T cells may be an effective treatment for patients with progressive multifocal...
Bernard Maria, MD, MBA, Director of the Division of Child Neurology and Developmental Medicine at Goryeb Children’s Hospital in Morristown, NJ,...
ROCKVILLE, MD—The FDA has approved galcanezumab-gnlm (Emgality) for the preventive treatment of migraine in adults. Eli...